Medication-Related Impulse Control and Repetitive Behaviors in Parkinson Disease

Diagnostic and Statistical Manual of Mental Disorders

Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,841 · see citing works

Neural systems of reinforcement for drug addiction: from actions to habits to compulsion

Everitt, B. J., & Robbins, T. W. (2005) · Nature Neuroscience · doi:10.1038/nn1579 · Cited by 3,785 · see citing works

Discrete coding of reward probability and uncertainty by dopamine neurons

Fiorillo, C. D., Tobler, P. N., & Schultz, W. (2003) · Science · doi:10.1126/science.1077349 · Cited by 2,085 · see citing works

By Carrot or by Stick: Cognitive Reinforcement Learning in Parkinsonism

Frank, M. J., Seeberger, L. C., & O'Reilly, R. C. (2004) · Science · doi:10.1126/science.1102941 · Cited by 1,964 · see citing works

Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans

Pessiglione, M., Seymour, B., Flandin, G., Dolan, R. J., & Frith, C. D. (2006) · Nature · doi:10.1038/nature05051 · Cited by 1,584 · see citing works

Estimating the prevalence of disordered gambling behavior in the United States and Canada: a research synthesis.

Shaffer, H. J., Hall, M. N., & Bilt, J. V. (1999) · American Journal of Public Health · doi:10.2105/ajph.89.9.1369 · Cited by 1,253 · see citing works

Dopaminergic modulation of cognitive function-implications for l-DOPA treatment in Parkinson's disease

Cools, R. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.024 · Cited by 903 · see citing works

Should addictive disorders include non-substance-related conditions?

Potenza, M. N. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01591.x · Cited by 663 · see citing works

Association of dopamine agonist use with impulse control disorders in Parkinson disease

Weintraub, D., Siderowf, A. D., Potenza, M. N., Goveas, J., Morales, K. H., Duda, J. E., Moberg, P. J., & Stern, M. B. (2006) · Archives of Neurology · doi:10.1001/archneur.63.7.969 · Cited by 662 · see citing works

Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies

Giovannoni, G. (2000) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.68.4.423 · Cited by 587 · see citing works

Pathological Gambling Caused by Drugs Used to Treat Parkinson Disease

Dodd, M. L., Klos, K. J., Bower, J. H., Geda, Y. E., Josephs, K. A., & Ahlskog, J. E. (2005) · Archives of Neurology · doi:10.1001/archneur.62.9.noc50009 · Cited by 563 · see citing works

Differential Actions of Antiparkinson Agents at Multiple Classes of Monoaminergic Receptor. I. A Multivariate Analysis of the Binding Profiles of 14 Drugs at 21 Native and Cloned Human Receptor Subtypes

Millan, M. J., Maiofiss, L., Cussac, D., Audinot, V., Boutin, J. A., & Newman‐Tancredi, A. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.039867 · Cited by 485 · see citing works

Compulsive drug use linked to sensitized ventral striatal dopamine transmission.

Evans, A. H., Pavese, N., Lawrence, A. D., Tai, Y. F., Appel, S., Doder, M., Brooks, D. J., Lees, A. J., & Piccini, P. (2006) · Annals of Neurology · doi:10.1002/ana.20822 · Cited by 473 · see citing works

Prevalence of repetitive and reward-seeking behaviors in Parkinson disease

Voon, V., Hassan, K. T., Zurowski, M., de Souza, M., Thomsen, T. R., Fox, S. H., Lang, A. E., & Miyasaki, J. M. (2006) · Neurology · doi:10.1212/01.wnl.0000238503.20816.13 · Cited by 417 · see citing works

Dopaminergic modulation of cortical function in patients with Parkinson's disease

Mattay, V. S., Tessitore, A., Callicott, J. H., Bertolino, A., Goldberg, T. E., Chase, T. N., Hyde, T. M., & Weinberger, D. R. (2002) · Annals of Neurology · doi:10.1002/ana.10078 · Cited by 402 · see citing works

Punding in Parkinson's disease: Its relation to the dopamine dysregulation syndrome

Evans, A., Katzenschlager, R., Paviour, D. C., Appel‐Cresswell, S., Lawrence, A., & Lees, A. J. (2004) · UCL Discovery (University College London) · Cited by 401 · see citing works

Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function

Bézard, E., Ferry, S., Mach, U., Stark, H., Leriche, L., Boraud, T., Gross, C. E., & Sokoloff, P. (2003) · Nature Medicine · doi:10.1038/nm875 · Cited by 383 · see citing works

Parkin disease: a phenotypic study of a large case series

Khan, N. L., Graham, E., Critchley, P., Schrag, A. E., Wood, N. W., Lees, A. J., Bhatia, K. P., & Quinn, N. P. (2003) · Brain · doi:10.1093/brain/awg142 · Cited by 352 · see citing works

Prospective prevalence of pathologic gambling and medication association in Parkinson disease

Voon, V., Hassan, K. T., Zurowski, M., Duff-Canning, S. J., de Souza, M., Fox, S. H., Lang, A. E., & Miyasaki, J. M. (2006) · Neurology · doi:10.1212/01.wnl.0000218206.20920.4d · Cited by 323 · see citing works

Pathological gambling: a comprehensive review of biobehavioral findings

Goudriaan, A. E., Oosterlaan, J., de Beurs, E., & Van den Brink, W. (2004) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2004.03.001 · Cited by 313 · see citing works

Factors Associated With Dopaminergic Drug–Related Pathological Gambling in Parkinson Disease

Voon, V., Thomsen, T. R., Miyasaki, J. M., de Souza, M., Shafro, A., Fox, S. H., Duff-Canning, S. J., Lang, A. E., & Zurowski, M. (2007) · Archives of Neurology · doi:10.1001/archneur.64.2.212 · Cited by 308 · see citing works

Compulsive eating and weight gain related to dopamine agonist use

Nirenberg, M. J., & Waters, C. (2005) · Movement Disorders · doi:10.1002/mds.20757 · Cited by 261 · see citing works

Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation

Ardouin, C., Voon, V., Worbe, Y., Abouazar, N., Czernecki, V., Hosseini, H., Pélissolo, A., Moro, E., Lhommée, E., Lang, A. E., et al. (2006) · Movement Disorders · doi:10.1002/mds.21098 · Cited by 257 · see citing works

Clinical features associated with impulse control disorders in Parkinson disease

Pontone, G. M., Williams, J. R., Bassett, S. S., & Marsh, L. (2006) · Neurology · doi:10.1212/01.wnl.0000238401.76928.45 · Cited by 218 · see citing works

Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease

Evans, A. H., Lawrence, A. D., Potts, J., Appel, S., & Lees, A. J. (2005) · Neurology · doi:10.1212/01.wnl.0000184487.72289.f0 · Cited by 207 · see citing works

Problematic gambling on dopamine agonists: Not such a rarity

Grosset, K. A., Macphee, G. J. A., Pal, G., Stewart, D. A., Watt, A., Davie, J., & Grosset, D. G. (2006) · Movement Disorders · doi:10.1002/mds.21110 · Cited by 167 · see citing works

Medication-related impulse control and repetitive behaviors in Parkinson??s disease

Voon, V., Potenza, M. N., & Thomsen, T. R. (2007) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32826fbc8f · Cited by 162 · see citing works

Prevalence of pathological gambling in patients with Parkinson's disease

Avanzi, M., Baratti, M., Cabrini, S., Uber, E., Brighetti, G., & Bonfà, F. (2006) · Movement Disorders · doi:10.1002/mds.21072 · Cited by 158 · see citing works

Efficacy of unilateral deep brain stimulation of the vim nucleus of the thalamus for essential head tremor

Koller, W. C., Lyons, K. E., Wilkinson, S. B., & Pahwa, R. (1999) · Movement Disorders · doi:10.1002/1531-8257(199909)14:5 · Cited by 132 · see citing works

Gambling and Parkinson Disease

Lu, C., Bharmal, A., & Suchowersky, O. (2006) · Archives of Neurology · doi:10.1001/archneur.63.2.298-a · Cited by 96 · see citing works

Pharmacological characterization of psychosis‐like behavior in the MPTP‐lesioned nonhuman primate model of Parkinson's disease

Visanji, N. P., Gómez-Ramírez, J., Johnston, T. H., Pires, D., Voon, V., Brotchie, J. M., & Fox, S. H. (2006) · Movement Disorders · doi:10.1002/mds.21073 · Cited by 92 · see citing works

Stereotyped behaviors or punding after quetiapine administration in Parkinson's disease

Miwa, H., Morita, S., Nakanishi, I., & Kondo, T. (2003) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2003.08.002 · Cited by 57 · see citing works

Dopamine Receptor Agonists and Levodopa and Inducing Psychosis-Like Behavior in the MPTP Primate Model of Parkinson Disease

Fox, S. H., Visanji, N. P., Johnston, T. H., et al. (2006) · Archives of Neurology · doi:10.1001/archneur.63.9.1343 · Cited by 57 · see citing works

Prevalence of repetitive and rewardseeking behaviors in Parkinson disease

Verma, A. (2007) · Yearbook of Neurology and Neurosurgery · doi:10.1016/s0513-5117(08)70073-5 · Cited by 34 · see citing works

Cell-phone addiction: a review

De-Sola Gutiérrez, J., Rodríguez de Fonseca, F., & Rubio, G. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00175 · Cited by 722 · see citing works

Validation of the questionnaire for impulsive‐compulsive disorders in Parkinson's disease

Weintraub, D., Hoops, S., Shea, J. A., Lyons, K. E., Pahwa, R., Driver‐Dunckley, E. D., Adler, C. H., Potenza, M. N., Miyasaki, J., Siderowf, A. D., et al. (2009) · Movement Disorders · doi:10.1002/mds.22571 · Cited by 528 · see citing works

Clinical spectrum of impulse control disorders in Parkinson’s disease

Weintraub, D., David, A. S., Evans, A. H., Grant, J. E., & Stacy, M. (2015) · Movement Disorders · doi:10.1002/mds.26016 · Cited by 311 · see citing works

Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours

O'Sullivan, S. S., Wu, K., Politis, M., Lawrence, A. D., Evans, A. H., Bose, S. K., Djamshidian, A., Lees, A. J., & Piccini, P. (2011) · Brain · doi:10.1093/brain/awr003 · Cited by 297 · see citing works

Mechanisms underlying dopamine-mediated reward bias in compulsive behaviors

Voon, V., Pessiglione, M., Brezing, C., Gallea, C., Fernandez, H. H., Dolan, R. J., & Hallett, M. (2010) · Neuron · doi:10.1016/j.neuron.2009.12.027 · Cited by 280 · see citing works

Dopamine Dysregulation Syndrome: An Overview of its Epidemiology, Mechanisms and Management

OʼSullivan, S. S., Evans, A. H., & Lees, A. J. (2009) · CNS Drugs · doi:10.2165/00023210-200923020-00005 · Cited by 265 · see citing works

Longitudinal analysis of impulse control disorders in Parkinson disease

Corvol, J.-C., Artaud, F., Cormier-Dequaire, F., Rascol, O., Durif, F., Derkinderen, P., Marques, A.-R., Bourdain, F., Brandel, J.-P., Pico, F., et al. (2018) · Neurology · doi:10.1212/wnl.0000000000005816 · Cited by 253 · see citing works

Dopamine agonists and risk: impulse control disorders in Parkinson's; disease

Voon, V., Gao, J., Brezing, C., Symmonds, M., Ekanayake, V., Fernandez, H., Dolan, R. J., & Hallett, M. (2011) · Brain · doi:10.1093/brain/awr080 · Cited by 209 · see citing works

Trial of CBT for impulse control behaviors affecting Parkinson patients and their caregivers

Okai, D., Askey-Jones, S., Samuel, M., O’Sullivan, S. S., Chaudhuri, K. R., Martin, A., Mack, J., Brown, R. G., & David, A. S. (2013) · Neurology · doi:10.1212/wnl.0b013e3182840678 · Cited by 202 · see citing works

A systematic review of impulse control disorders in Parkinson’s disease.

Callesen, M. B., Scheel-Krüger, J., Kringelbach, M. L., & Møller, A. (2013) · Journal of Parkinson s Disease · doi:10.3233/jpd-120165 · Cited by 130 · see citing works

Depression and impulse control disorders in Parkinson׳s disease: two sides of the same coin?

Vriend, C., Pattij, T., van der Werf, Y. D., Voorn, P., Booij, J., Rutten, S., Berendse, H. W., & van den Heuvel, O. A. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.11.001 · Cited by 106 · see citing works

Frontal-striatal abnormalities underlying behaviours in the compulsive-impulsive spectrum

den Heuvel, O. A. V., der Werf, Y. D. V., Verhoef, K. M. W., de Wit, S., Berendse, H. W., Wolters, E. C., Veltman, D. J., & Groenewegen, H. J. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.08.043 · Cited by 105 · see citing works

Dopamine Agonists and the Suppression of Impulsive Motor Actions in Parkinson Disease

Wylie, S. A., Claassen, D. O., Huizenga, H. M., Schewel, K. D., Ridderinkhof, K. R., Bashore, T. R., & van den Wildenberg, W. P. M. (2012) · Journal of Cognitive Neuroscience · doi:10.1162/jocn_a_00241 · Cited by 76 · see citing works

Impulse control disorders in Parkinson's disease

Vilas, D., Pont-Sunyer, C., & Tolosa, E. (2012) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(11)70026-8 · Cited by 77 · see citing works

Paraphilias and paraphilic disorders in Parkinson's disease: a systematic review of the literature

Solla, P., Bortolato, M., Cannas, A., Mulas, C. S., & Marrosu, F. (2015) · Movement Disorders · doi:10.1002/mds.26157 · Cited by 46 · see citing works

The Effect of Dopamine Agonists on Adaptive and Aberrant Salience in Parkinson's Disease

Nagy, H., Levy-Gigi, E., Somlai, Z., Takáts, A., Bereczki, D., & Kéri, S. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.278 · Cited by 42 · see citing works

[Impulse control disorders and Parkinson's disease].

Burkhard, P. R., Chiuvé, S. C., Gronchi‐Perrin, A., et al. (2008) · PubMed · Cited by 12 · see citing works

Drug-induced impulse control disorders in Parkinson’s disease

Reiff, J., & Jost, W. H. (2011) · Journal of Neurology · doi:10.1007/s00415-011-5932-1 · Cited by 13 · see citing works

An Update on Impulse Control Disorders in Parkinson’s Disease

Voon, V., & Mehta, A. R. (2012) · Advances in biological psychiatry · doi:10.1159/000331655 · Cited by 1 · see citing works

Pet Killing as a Manifestation of Impulse Control Disorder Secondary to Pramipexol

Micheli, F. E., Pellene, A., Arcushin, D., Calzinari, A., & Sáenz‐Farret, M. (2015) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000074 · Cited by 13 · see citing works

Behavioral Variant Frontotemporal Degeneration or Parkinson’s Disease? Not All Hypersexuality Is Impulse Control Disorder (P6.387)

Young, K. J., McDonell, K. E., & Claassen, D. O. (2016) · Neurology · doi:10.1212/wnl.86.16_supplement.p6.387 · Cited by 1 · see citing works